Objectives

1.Review the role of medications in dementia prevention with a focus on a multidomain approach.

2.Review the indications for treatment with a cholinesterase inhibitor and/or memantine, the side effects and contraindications, and when to deprescribe.

3.Discuss disease modifying drugs for Alzheimer’s dementia that may be available in Canada in the future.

4.Review the guidelines on the pharmacological management of neuropsychiatric symptoms of dementia.